Reaction profile

The FDA adverse-event record for founder

22 FDA reports name founder, a lower-volume reaction in the CVM extract (VeDDRA 616). Plate stamps and neighbourhood peers follow.

#2125 of 2,481
by report volume (all reactions)
22
reports citing this reaction
27.3%
death-coded share
Horse
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Founder has 22 reports now versus 20 in that prior snapshot: 2 more (10.0%).

Report change
+2
Death-coded reports
+0
Death-coded share
−2.7 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Founder changes

FDA AER · VeDDRA plate

Code 616 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-HORSE · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 22 reports
  • DEATH-HOT 27.3%
  • LOWER-Q #2125/2481
  • PHOTO-FINISH Adenocarcinoma NOS
  • SPECIES-HORSE Horse · 17
  • DRUG-LEAD Pergolide Mesylate · 7
  • DESK-WIDE 13 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Adenocarcinoma NOS (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Founder

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Adenocarcinoma NOS · near22Bolus, Abnormal · near22Bone marrow aplasia · near22CEREBROSPINAL FLUID A… · near22Founder · this reaction22Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Founder

Founder: high death-coded share in the FDA AER plate

Signature read: 22 reports place Founder in the lower third of FDA AER volume (#2125 of 2,481). Report volume is lower-third scale: 22 named reports in the openFDA extract. Death-coded share is upper-third: 6 of 22 reports (27.3% of named reports). Nearest volume peer: Adenocarcinoma NOS (±0 reports). Lead species Horse (17). Lead co-reported drug Pergolide Mesylate (7).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Horse 17
Cattle 4
Donkey 1

Breeds Most Affected

Horse (unknown) 4
Quarter Horse 4
Thoroughbred 3
Aberdeen Angus 2
Donkey (unknown) 1
Cattle (unknown) 1
Mixed (Cattle) 1
Trakehner 1
Palomino 1
Horse (other) 1

Associated Drugs

Pergolide Mesylate 7
Monensin Sodium 4
Polysulfated Glycosaminoglycan 2
Tylosin Tartrate 2
Firocoxib 0.82% 1
Ractopamine Hydrochloride 1
Triamcinolone Acetonide 1
Ewt Vaccine 1
West Nile Vaccine 1
Flu/Rhino Vaccine 1
Hyaluronic Acid Injection 1
Bute Paste 1
Amikacin 1
Detomidine Hydrochloride 1
Lasalocid Sodium 1
Pergolide 1
Fenbendazol Oral Paste 1
Hcg (Fd) Injectable 1
Joint Supplement (Unspecified) 1
Rabies Virus,Pv-11,Killed 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Founder (#2125 of 2,481 by report volume); death-coded 27.3%. PlainBreed reaction plate · report volume stamp 22 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →